Advanced Search

Study Preview



Study Title and Description

Phase 2b trial of interferon-free therapy for hepatitis C virus genotype 1.



Key Questions Addressed
7 Key Question 7. What is the effectiveness of currently recommended antiviral treatments in achieving a SVR in patients with HCV infection?
  • Comments Comments (
    0
    ) |
8 Key Question 8. What are the harms of currently recommended antiviral treatments?
  • Comments Comments (
    0
    ) |

Primary Publication Information
  • Comments Comments (
    0
    ) |
TitleData
Title Phase 2b trial of interferon-free therapy for hepatitis C virus genotype 1.
Author Kowdley KV., Lawitz E., Poordad F., Cohen DE., Nelson DR., Zeuzem S., Everson GT., Kwo P., Foster GR., Sulkowski MS., Xie W., Pilot-Matias T., Liossis G., Larsen L., Khatri A., Podsadecki T., Bernstein B.
Country From the Digestive Disease Institute, Virginia Mason Medical Center, Seattle (K.V.K.); Texas Liver Institute, University of Texas Health Science Center, San Antonio (E.L., F.P.); AbbVie, North Chicago (D.E.C., W.X., T.P.-M., G.L., L.L., A.K., T.P., B.B.); University of Florida College of Medicine, Gainesville (D.R.N.); J.W. Goethe University, Frankfurt, Germany (S.Z.); University of Colorado Denver, Aurora (G.T.E.); Indiana University, Indianapolis (P.K.); Queen Mary, University of London, Barts Health, London (G.R.F.); and Johns Hopkins University, Baltimore (M.S.S.).
Year 2014
Numbers Pubmed ID: 24428468

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: Key Questions 1-9


Results & Comparisons

No Results found.